Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma

Figure 4 Expression of FABP5 correlates with cancer hallmark G2M checkpoint and genes within. A: FABP5 positively correlated with enrichment of cancer hallmark G2M checkpoint in patients with liver hepatocellular carcinoma (LIHC); B: Gene list included in the cancer hallmark G2M checkpoint. The genes that showed positive correlation with FABP5 are highlighted in red (P < 0.01); C: Highlighted genes in the G2M checkpoint gene set positively correlate with FABP5 expression in patients with LIHC. P values show the statistical significance of the correlation; R values indicate the correlation coefficient; D: Altered expression of individual genes in the G2M checkpoint gene set showed in the context of signaling network. Pink bars show upregulation of gene expression.